Académique Documents
Professionnel Documents
Culture Documents
Selectively inhibit bacterial protein synthesis Protein synthesis in microorganisms is not identical to mammalian cells 70S ribosomes in bacteria 80S ribosomes in mammalians
Basis for selective toxicity against microorganisms without causing major effects on mammalian cells Differences Ribosomal subunits Chemical composition Functional specificities of component nucleic acids and proteins
BROAD SPECTRUM
MODERATE SPECTRUM
NARROW SPECTRUM
CHLORAMPHENICOL
MACROLIDES
TETRACYCLINES
MECHANISM OF ACTION Bacteriostatic inhibitors of protein synthesis 50S ribosome unit Except of tetracycline
Tetracyclines
Antimicrobia activity broad spectrum antibiotics: effective against a large no of organisms:
Atypical organisms (like Chlamydia spp, Legionella spp, Rickettsiae, Mycoplasma pneumoniae) Some atypical mycobacteria Camplylobacter jejuni Helicobacter pylori. A variety of gram-positive, gram-negative organisms: vibrio cholerae, plague, tularemia, brucellosis. For protozoal infection- E. Histolytica, P.falciparum. Effective against many anaerobes (doxycycline)
Classification Older tetracyclines: 1. Short acting (half life 6 hours)-Tetracycline, chlortetracycline, oxytetracycline 2. Intermediate acting- half life 16 hoursdemeclocycline Newer ones : 3. Long acting half life-18-24 hours- doxycycline and minocycline are more lipophilic and most active. 4. Longest acting: Tigecycline- newest half life-36 hours
Tetracyclines
Mechanism of action Bacteriostatic agents. Inhibit protein synthesis via reversible binding to 30 s ribosome, block the binding of aminoacyl tRNA to the acceptor site on mRNA. This prevents addition of aminoacid to growing polypeptide. Resistance : Dec. accumulation due to dec. influx, or inc. efflux. Dec. access to ribosome due to presence of ribosome protection proteins Enzymatic inactivation of tetracycline
ADME of tetracyclines
Absorption: Doxycycline & minocycline- 100%. Food does not interfere with their abs. Abs. of others is dec. by concurrent adm. of dairy products alum, Ca++, Mg, Bi & iron salts- due to chelation of divalent or trivalent cations. Distribution Protein binding 40-80% Conc. in liver, exc. in int. via bile-EHC. Widely distributed in tissues except CSF- On I.V: appear in spinal fluid. Tetracyclines cross placenta High conc. found in breast milk.
Metabolism
Minocycline, doxycycline and tigecycline metabolized in liver. Doxycycline is exc. in feces- preferred to treat extra renal infection in patients with renal failure. Enzyme inducers dec. their half lives.
Excretion
All tetracyclines are exc. in urine and feces (bile).
Precautions
Pregnancy, lactation and in children 8 years. In patients with renal or hepatic disease Dont use expired preparations.
Uses
DOC for infections produced by : chlamydiae; rickettsia; mycoplasma, legionella infections. Vibrio cholera. In combination with aminoglycosides: plague, brucellosis, tularemia. Other uses: Exacerbation of chronic bronchitis CAP Treatment of acne & skin infections. Tetracycline for eradication of H.pylori Doxycycline: lyme disease (1st choice); and prophylaxis of chloroquine resistant P. falciparum malaria
TETRACYCLINES A. CLASSIFICATION Structural congeners Broad range of antimicrobial activity Minor differences in activity against organisms
TETRACYCLINES C. ANTIBACTERIAL ACTIVITY Plasmid-mediated resistance is widespread Decrease activity of the uptake systems Development of efflux pumps for active extrusion of the drug
CHLORAMPHENICOL, TETRACYCLINES, MACROLIDES, CLINDAMYCIN, STREPTOGRAMINS, & LINEZOLID TETRACYCLINES D. CLINICAL USES 1. Primary uses Tetracyclines M. pneumoniae (in adults) Chlamydia Rickettsia Vibrio cholera Drug of choice
CHLORAMPHENICOL, TETRACYCLINES, MACROLIDES, CLINDAMYCIN, STREPTOGRAMINS, & LINEZOLID TETRACYCLINES D. CLINICAL USES 2. Secondary uses Tetracyclines Alternative drug for syphilis Respiratory infections caused by susceptible organisms Prophylaxis against chronic bronchitis Leptospirosis Treatment of acne
CHLORAMPHENICOL, TETRACYCLINES, MACROLIDES, CLINDAMYCIN, STREPTOGRAMINS, & LINEZOLID TETRACYCLINES D. CLINICAL USES 3. Selective uses Minocycline Meningococcal carrier state Doxycycline Prevention of malaria Treatment of amoebiasis
CHLORAMPHENICOL, TETRACYCLINES, MACROLIDES, CLINDAMYCIN, STREPTOGRAMINS, & LINEZOLID TETRACYCLINES E. TOXICITY 1. GI disturbances Mild nausea and diarrhea to severe, possibly life-threatening colitis Disturbances in the normal flora Candidiasis (oral and vaginal) Bacterial superinfection S. aureus or C. difficile Rare
CHLORAMPHENICOL, TETRACYCLINES, MACROLIDES, CLINDAMYCIN, STREPTOGRAMINS, & LINEZOLID TETRACYCLINES E. TOXICITY 2. Bony structures and teeth Younger children (under age 8) Enamel dysplasia and crown deformation when permanent teeth appears Bind with calcium and deposit in newly formed bones (impaired long bone formation ) and teeth (discolouration of teeth)
TETRACYCLINES E. TOXICITY 4. Renal toxicity Fanconis syndrome Renal tubular acidosis Intake of outdated tetracycline
Tigecycline
Effective against: Certain tetracycline resistant strains of organisms; MRSA; vancomycin resistant staph; VREnterococci, Strep (penicillin susceptible & resistant); G+ve rods; enterobacteriaceae; multidrug resistant acinetobacter spp; anaerobes (G+ve, G-ve); atypical agents: rickettisiae, chlamydia, legionella, rapidly growing mycobacteria. Proteus and pseudomonas are intrinsically resistant.
Uses
Multidrug resistant nosocomial pathogens (MRSA, extended spectrum beta lactamase producing G ve organisms & acinetobacter spp. Treatment of skin & skin structure infections & intraabdominal infections. Not for UTI (not effective conc in urine).
Chloramphenicol
Mechanism of action Inhibits protein synthesis, binds reversibly to 50 S ribosomal subunit, prevents binding of aminoacyl tRNA to 50 S ribosomes, inhibits peptidyl transferase step in protein synthesis. Also inhibits mitochondrial protein synthesis by acting on 70 S ribosomemammalian erythropoietic cells are particularly sensitive to the drug. Bacteriostatic, bactericidial for H.influanzae, N.meningitidis & S.pneumoniae
Antimicrobial spectrum: broad spectrum (G + ve & ve orga. aerobes and most anaerobes) Effective against H. influenzae, N. meningitidis, Salmonella typhi, Brucella species, Bordetella pertussis & anaerobes- highly susceptible. Effective against Rickettsiae, Mycoplasma & Chlamydia. Resistance to chloramphenicol: Acetylation of chloramphenicol due to plasmid encoded acetyl transferase. Acetylated drug fails to bind to bacterial ribosomes. Dec. permeability of the microorganisms (E. Coli).
Chloramphenicol ADME
Well absorbed orally. Distributed in body fluids- CSF conc. 60%, crosses placental barrier & aqueous humor. Metabolized in the liver by glucuronidation by glucuronyl transferase. Drug interactions Irreversible inhibition of CYP P450 leads to inc. half-life of warfarin, phenytoin, tolbutamide, etc. Enzyme inducers (rifampin, phenobarbitone) shorten the T of chloramphenicol.
Adverse effects
1. Hematological toxicity: i Idiosyncratic reaction (dose independent)- aplastic anemia: leukopenia, thrombocytopenia & aplasia of marrow. May be fatal or may lead to acute myeloblastic leukemia later on. ii A 2nd dose related hematological effect: reversible suppression of bone marrow with conc. > 25 g/ml. iii. Hemolytic anemia in G6PD deficiency 2. Toxic and irritable effects Fatal chloramphenicol toxicity (conc >100 g/ml) - in neonate esp. in premature - called "gray baby syndrome" -due to failure of glucuronidation (lack of glucuronyl transferase in first 3-4 weeks of life, & dec. renal function) Optic neuritis, peripheral neuritis. 3. Hypersensitivity reactions. 4. GI disturbances: N,V, D. 5. Superinfection: oral or vaginal candidiasis due to alteration of normal flora.
Therapeutic uses
Because of potential toxicity, bacterial resistance & availability of effective alternative drugs, it is rarely used. Should never be used for minor infections, or infections which could be treated by other drugs.
Second choice drug in 1 Typhoid fever: 2. Bacterial meningitis. 3. rickettsial infection and 4. Anaerobic infection- Brain abscess. 5. Intraocular infection 6. Topical use: conjunctivitis and external ear infections.
CHLORAMPHENICOL A. CLASSIFICATION Enterohepatic cycling Fraction excreted in urine unchanged Inactivated by hepatic glucoronosyltransferase
CHLORAMPHENICOL B. ANTIMICROBIAL ACTIVITY Not effective for chlamydia Resistance Plasmid mediated-formation of acetyltransferases that inactivate the drug
CHLORAMPHENICOL C. CLINICAL USES Few uses as systemic drug because of toxicity Backup drug for severe infections caused by salmonella Treatment of pneumococcal and meningococcal meningitis in beta-lactam-sensitive persons
CHLORAMPHENICOL C. CLINICAL USES Sometimes used for ricketssial infections Infections caused by anaerobes like B. fragilis Commonly used as topical agent
CHLORAMPHENICOL D. TOXICITY 2. Bone marrow Inhibition of red cell maturation in circulating RBC Reversible
decrease
CHLORAMPHENICOL D. TOXICITY 3. Aplastic anemia Rare idiosyncratic reaction Irreversible and maybe fatal
MECHANISM OF ACTION Linezolid Bacteriostatic Binds to a unique site at 50S Blocks formation of tRNA-ribosomemRNA complex
CHLORAMPHENICOL, TETRACYCLINES, MACROLIDES, CLINDAMYCIN, STREPTOGRAMINS, & LINEZOLID MACROLIDES A. CLASSIFICATION AND PHARMACOKINETICS Azithromycin Absorption is impeded by food Levels in tissues and phagocytes are higher than in plasma Eliminated slowly in the urine mainly as unchanged drug Half-life is 2-4 days
MACROLIDES D. TOXICITY GI irritation is common Stimulation of motolin receptors Skin rashes Eosinophilia
CHLORAMPHENICOL, TETRACYCLINES, MACROLIDES, CLINDAMYCIN, STREPTOGRAMINS, & LINEZOLID MACROLIDES D. TOXICITY Clarithromycin Similar drug interactions of erythromycin can occur Azithromycin Structure of lactone ring is slightly different Drug interactions are uncommon Does not inhibit hepatic cytochrome P450
TELITHROMYCIN Ketolide Structurally related to macrolides Same MOA as erythromycin Similar spectrum of antimicrobial activity Some macrolide-resistant strains are susceptible because it binds more tightly to ribosomes
TELITHROMYCIN Poor substrate for bacterial efflux pump that mediate resistance CAP and other upper respiratory tract infections Given orally once daily Eliminated in the bile and urine Inhibitor of cytochrome CYP3A4 isozyme
CLINDAMYCIN A. CLASSIFICATION AND PHARMACOKINETICS Resistance Methylation of the binding site on 50S Enzymatic inactivation Cross-resistance with macrolides is common
CLINDAMYCIN A. CLASSIFICATION AND PHARMACOKINETICS Orally absorbed Good tissue penetration Eliminated partly by metabolism and partly by biliary and renal excretion
CHLORAMPHENICOL, TETRACYCLINES, MACROLIDES, CLINDAMYCIN, STREPTOGRAMINS, & LINEZOLID STREPTOGRAMINS Quinupristin-dalfopristin Combination of 2 streptogramins Bactericidal Postantibiotic effect Duration of bacterial activity is longer than the half-lives of the 2 compounds Used for PRP, MRSA and vancomycin-resistant staphylococci (VRSA) and resistant E. faecium